Sydnexis Receives Complete Response Letter from FDA for SYD-101 to Slow Pediatric Myopia Progression
DEL MAR, Calif.--(BUSINESS WIRE)--Sydnexis, Inc., (www.sydnexis.com), a biopharmaceutical company focused on pediatric progressive myopia (PPM), today announced that the U.S. Food and Drug ...
Cryptopolitan on MSN
The 8 best crypto exchange APIs in 2026
Crypto exchanges provide developers with APIs to connect with their trading engine and data feeds. The APIs cover a dozen ...
You might’ve heard that Phillies starter Cristopher Sánchez just recorded one of the best calendar months the sport has seen in a very, very long time. He has thrown 44 2/3 consecutive scoreless ...
IBM DataPower Gateway uses crypto certificate objects, crypto key objects, and validation credentials to secure REST API traffic across enterprise environments. The REST Management Interface on port ...
Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. World Health Organization officials ...
In the absence of head-to-head randomized trials, ImmunityBio conducted a matching-adjusted indirect comparison (MAIC) using individual patient data from QUILT-3.032 (Cohort A, NAI+BCG, n=100) ...
Winning a national championship requires elite talent and quality depth. Only a handful of programs entering the 2026 season can check both boxes as legitimate title contenders with complete rosters.
An SDK (Software Development Kit) is a pre-built package that makes using an API easy. Instead of writing complex network requests from scratch, the SDK gives you simple Python functions that handle ...
OpenAI said Thursday that its API will now include a number of new voice intelligence features designed to help developers create apps that can talk, transcribe, and translate conversations with users ...
Highlights of Python 3.15, now available in beta, include lazy imports, faster JITs, better error messages, and smarter profiling. The first full beta of Python 3.15 ...
The FDA has doled out two manufacturing-related complete response letters (CRLs), slamming the brakes on prospective therapies from AbbVie and Grace Therapeutics. For AbbVie, the Chicago drugmaker had ...
Please provide your email address to receive an email when new articles are posted on . TrenibotulinumtoxinE is a fast-acting, short-term neurotoxin for treatment of glabellar lines. The FDA’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results